Valvular Heart Disease in Hyperprolactinemic Patients Treated With Low Doses of Cabergoline

被引：10

作者：

Cordoba-Soriano, Juan G. ^{[1
]}

Lamas-Oliveira, Cristina ^{[2
]}

Hidalgo-Olivares, Victor M. ^{[1
]}

Tercero-Martinez, Antonia ^{[1
]}

Barambio-Ruiz, Moises ^{[1
]}

Salas-Nieto, Jesus ^{[1
]}

机构：

[1] Hosp Gen Univ Albacete, Serv Cardiol, Albacete, Spain

[2] Hosp Gen Univ Albacete, Serv Endocrinol, Albacete, Spain

来源：

REVISTA ESPANOLA DE CARDIOLOGIA | 2013年 / 66卷 / 05期

关键词：

FENFLURAMINE;

D O I：

10.1016/j.rec.2012.10.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：410 / 412

页数：4

共 6 条

[1] Drug-induced fibrotic valvular heart disease [J].

Bhattacharyya, Sanjeev ;

Schapira, Anthony H. ;

Mikhailidis, Dimitri P. ;

Davar, Joseph .

LANCET, 2009, 374 (9689) :577-585

[2] Valvular heart disease associated with fenfluramine-phentermine [J].

Connolly, HM ;

Crary, JL ;

McGoon, MD ;

Hensrud, DD ;

Edwards, BS ;

Edwards, WD ;

Schaff, HV .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588

[3] The Endocrine System and the Heart: A Review [J].

Rhee, Soo S. ;

Pearce, Elizabeth N. .

REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (03) :220-231

[4]

Rothman RB, 2000, CIRCULATION, V102, P2836

[5] Dopamine agonists and the risk of cardiac-valve regurgitation [J].

Schade, Rene ;

Andersohn, Frank ;

Suissa, Samy ;

Haverkamp, Wilhelm ;

Garbe, Edeltraut .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :29-38

[6] Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do [J].

Sherlock, Mark ;

Toogood, Andy A. ;

Steeds, Richard .

HEART, 2009, 95 (07) :522-523

← 1 →